Enhabit Inc. (EHAB) Stock
EHAB is no longer traded. Enhabit was delisted from the NYSE in May 2026.
Prices on this page are historical; the last trade was May 14, 2026 at $13.80.
Enhabit stock price history
EHAB final trading statistics
- Final close
- $13.80
- Final trading day
- May 14, 2026
- Market cap at delisting
- $706.91M
- Shares outstanding
- 51.23M
- Final 52-week range
- $6.47 – $14.22
- Avg. volume (final 3 mo.)
- 1,634,914
- All-time high (split-adj.)
- $25.00 · Jun 2022
- All-time low (split-adj.)
- $6.52 · Aug 2025
- Return since IPO
- -44.8%
- Beta
- 0.96
- Book value / share
- $10.53
- Price / book
- 1.31
Enhabit annual financials
| Fiscal year | Revenue | Net income | Adj. EPS |
|---|---|---|---|
| FY2025 | $1.06B | -$4.6M | $0.59 |
| FY2024 | $1.03B | -$156.2M | $0.21 |
| FY2023 | $1.05B | -$80.5M | $0.22 |
| FY2022 | $1.07B | -$40.4M | $1.55 |
| FY2021 | $1.11B | $111.1M | — |
Last five fiscal years reported before the delisting; fiscal year ending December. Adj. EPS is adjusted (non-GAAP) earnings per share as reported by the company, so it can differ from net income per share and can be positive in a year with a net loss. Source: company filings via EODHD.
About Enhabit Inc.
Enhabit, Inc. provides home health and hospice services in the United States. The Home Health segment offers nursing care; physical, occupational, and speech therapy; medical and social work; and home health aide services. This segment also provides patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care, and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery or injury, and respiratory diseases; and counseling for patients and their families regarding financial, personal, and social concerns that arise from a patient's health-related problems. Its Hospice segment offers nursing care; pain and symptom management; palliative and dietary counseling; social worker visits; spiritual counseling; and family member bereavement counseling to meet the individual physical, emotional, spiritual, and psychosocial needs of terminally ill patients and their families. The company was formerly known as Encompass Health Home Health Holdings, Inc. and changed its name to Enhabit, Inc. in March 2022. Enhabit, Inc. was founded in 1998 and is headquartered in Dallas, Texas.
Enhabit stock FAQ
What happened to Enhabit stock?
Enhabit stock was delisted from the NYSE. Its final close was $13.80 on May 14, 2026.
Is EHAB stock still trading?
No. EHAB was delisted from the NYSE in May 2026 and no longer trades on a U.S. exchange.
What was the last price of EHAB stock?
EHAB closed at $13.80 on its final trading day, May 14, 2026, for a market value of about $706.91M.
What were Enhabit's revenue and earnings in its last full fiscal year?
Enhabit reported revenue of $1.06B and net income of -$4.6M in fiscal 2025, its last full year as a public company.
When did Enhabit go public?
Enhabit Inc. stock began trading on July 1, 2022.